Paper5113220
A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment.
Halpern BL and 4 others. Johns Hopkins Med J, 1971. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. Papers, record 5113220. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5113220
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aortic Rupture | Major topic |
| Marfan Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Aortic Aneurysm | |
| Child | |
| Electrocardiography | |
| Female | |
| Follow-Up Studies | |
| Hemodynamics | |
| Humans | |
| Male | |
| Propranolol | |
| Radiography | |
| Sex Factors |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37160466 | Prophylactic effect of angiotensin receptor blockers in children with genetic aortopathies: the early bird catches the worm. | Clin Res Cardiol | 2023 | https://conductscience.org/library/papers/37160466 | PubMed |
| 36049495 | Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. | Lancet | 2022 | https://conductscience.org/library/papers/36049495 | PubMed |
| 35233355 | An update of medical care in Marfan syndrome. | Tzu Chi Med J | 2022 | https://conductscience.org/library/papers/35233355 | PubMed |
| 35139623 | Intensive care unit management of uncomplicated type B aortic dissection in relation to treatment period: a retrospective observational study. | J Yeungnam Med Sci | 2022 | https://conductscience.org/library/papers/35139623 | PubMed |
| 34408505 | An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome. | J Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34408505 | PubMed |
| 30765726 | In vivo characterization of doxycycline-mediated protection of aortic function and structure in a mouse model of Marfan syndrome-associated aortic aneurysm. | Sci Rep | 2019 | https://conductscience.org/library/papers/30765726 | PubMed |
| 29541693 | Ruptured abdominal aortic aneurysm repair in pediatric Marfan syndrome patient. | J Vasc Surg Cases Innov Tech | 2018 | https://conductscience.org/library/papers/29541693 | PubMed |
| 29270371 | Etiology and pathogenesis of the Marfan syndrome: current understanding. | Ann Cardiothorac Surg | 2017 | https://conductscience.org/library/papers/29270371 | PubMed |
| 29110304 | Beta-blockers for preventing aortic dissection in Marfan syndrome. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29110304 | PubMed |
| 28607545 | The Genetics of Aortopathies in Clinical Cardiology. | Clin Med Insights Cardiol | 2017 | https://conductscience.org/library/papers/28607545 | PubMed |
| 25965707 | Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration. | Am Heart J | 2015 | https://conductscience.org/library/papers/25965707 | PubMed |
| 25109242 | β-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome. | J Pediatr | 2014 | https://conductscience.org/library/papers/25109242 | PubMed |
| 23198270 | Bicuspid aortic valve disease and ascending aortic aneurysms: gaps in knowledge. | Cardiol Res Pract | 2012 | https://conductscience.org/library/papers/23198270 | PubMed |
| 20425163 | The pathogenesis of aortopathy in Marfan syndrome and related diseases. | Curr Cardiol Rep | 2010 | https://conductscience.org/library/papers/20425163 | PubMed |
| 20351702 | Marfan syndrome. Part 2: treatment and management of patients. | Nat Rev Cardiol | 2010 | https://conductscience.org/library/papers/20351702 | PubMed |
| 20300261 | Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: A time for re-appraisal. | Ann Pediatr Cardiol | 2008 | https://conductscience.org/library/papers/20300261 | PubMed |
| 16325700 | Marfan's syndrome. | Lancet | 2005 | https://conductscience.org/library/papers/16325700 | PubMed |
| 9059160 | Evolving phenotype of Marfan's syndrome. | Arch Dis Child | 1997 | https://conductscience.org/library/papers/9059160 | PubMed |
| 8435232 | Elective replacement of the aortic root in Marfan's syndrome. | Br Heart J | 1993 | https://conductscience.org/library/papers/8435232 | PubMed |
| 3134980 | Diagnosing Marfan syndrome. | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/3134980 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5113220
GET https://conductscience.org/api/papers/v1/5113220/cited_by?page=2